Authorship and Contribution Policy

Vive Revista de Investigación en Salud defines authors as individuals who have significantly contributed to the research's conception and design, data acquisition, analysis, or interpretation, as well as the manuscript's drafting or critical revision, and who have approved the final version for publication. Based on the Contributor Roles Taxonomy (CRediT), authors must identify each contributor's role in the manuscript and document it in the accompanying submission letter.

Authors' order will reflect their prior agreement. The researcher submitting the manuscript via the platform is the corresponding author, exclusively managing all communication and follow-up throughout the editorial process.

Submissions to Vive Revista de Investigación en Salud must be strictly original and unpublished. By submitting, authors guarantee the manuscript is not under simultaneous review elsewhere. Submission also requires express consent from all co-authors, who commit to this exclusivity until a final decision (acceptance or rejection). (See: Submission Letter).

Authors must include:

• Pen name (consistent with scientific output, e.g., ORCID name).
• Email address.
• ORCID iD.
• Institutional affiliation (including city and country).

Authors are ethically obligated to notify and correct any manuscript errors detected at any process stage. Rectification requests must be formalized via email to the Editor at editor@revistavive.org.

Peer review decisions are communicated via Open Journal Systems (OJS). Strict adherence to reviewer observations and suggested corrections is mandatory for final article acceptance.

Before editorial production, authors must formalize the transfer of intellectual property rights to Vive Revista de Investigación en Salud. Each member must complete and sign the publisher's assignment form. This policy aligns with the Creative Commons license (CC BY 4.0), safeguarding authors' attribution rights.

The Editorial Committee of Vive Revista de Investigación en Salud reserves the right to adjust titles and text for optimal clarity, coherence, and communicative impact. Authors must submit manuscripts with impeccable spelling, concise and consistent paragraph structure, and technically precise punctuation to ensure academic quality.

Plagiarism Policy

Vive Revista de Investigación en Salud deems plagiarism strictly unacceptable. All submitted manuscripts must mandatorily comply with the following guidelines for potential acceptance:

• Works submitted to Vive Revista de Investigación en Salud must be original and unpublished, a condition guaranteed by all authors. Therefore, the official cover letter format is required, where the research team formally commits to these criteria. The journal does not permit publication of articles previously disseminated in other languages.
• Excessive fragmentation of large studies can mislead readers or indicate a lack of originality. Authors must cite their own previous publications when referenced. The corresponding author must also be available to address editor or reviewer inquiries about the manuscript's connection to their prior work.
• Every submitted article undergoes rigorous peer review and processing via specialized similarity detection software. Works failing to meet originality standards will be inadmissible. Should a lack of integrity be identified post-publication, the article will be retracted from the corresponding volume and issue.

Vive Revista de Investigación en Salud maintains an ethical commitment to its scientific community, thus issuing necessary retractions or errata to ensure transparency and due process for any anomaly detected or reported.

Authors assume full responsibility for all graphic and informational material (tables, charts, photographs, figures), explicitly declaring such content does not infringe third-party intellectual property rights and that the entire manuscript is an original work.

Manuscripts undergo strict review and plagiarism analysis to ensure no copying, unattributed paraphrasing, or inappropriate information management. Failure to meet originality criteria will result in submission rejection or, if found post-publication, formal article retraction.

Research Misconduct

Vive Revista de Investigación en Salud requires manuscripts to stem from rigorous scientific research. Authors must declare the study's origin and framework. During peer review, experts assess methodological soundness, result presentation, argumentative depth, and conclusion validity to ensure accuracy, relevance, and original contribution.

Researchers must maintain information traceability; the editorial team or reviewers may request access to databases and primary sources. Any indication of data or citation manipulation, falsification, or fabrication will lead to immediate and definitive manuscript rejection.

Consistent with author guidelines, submitted articles must be unpublished and not under simultaneous review elsewhere. Unpublished status is mandatory; all signatories commit to exclusivity with Vive Revista de Investigación en Salud until the final acceptance or rejection decision.

Editorial policy prohibits publishing works with inappropriate paraphrasing. When using ideas from various sources, direct quotes must be strictly delimited with quotation marks and attributed. The journal also reaffirms its non-republication policy: works previously disseminated in any language are not accepted.

Fragmentation

Vive Revista de Investigación en Salud holds that every contribution must possess an original scientific identity. As fragmenting extensive studies into multiple articles can create ambiguity and affect academic clarity, any reference to authors' previous works must be properly cited. Unnecessary information repetition compromising originality criteria must be avoided. The corresponding author must also address editor and reviewer inquiries regarding the manuscript's connection to their prior publications.

The journal reaffirms its ethical commitment to the scientific community. Upon detecting or reporting any post-publication anomaly, retractions or errata will be issued, ensuring transparency and adherence to due editorial process.

Use of Artificial Intelligence (AI) Resources (Chatbots)

1. The journal adopts the WAME Recommendations on ChatGPT and Chatbots in Relation to Scholarly Publications.
2. Only humans can be authors. Chatbots and AI tools cannot be authors.
3. The journal does not accept articles massively generated by one or more AI tools.
4. Authors must assume public responsibility for their work. Authors are responsible for chatbot-generated content in their article, including accuracy, absence of plagiarism, and proper attribution of all sources (including chatbot-produced material).
5. Editors use appropriate tools to help detect AI-generated or altered content.

Vive Revista de Investigación en Salud commits ethically to ensuring transparency and safeguarding the integrity and traceability of the scientific record. In health sciences, data veracity and process clarity are imperative. Therefore, the journal will manage rectifications after official article dissemination based on these criteria:

1. Erratum (Correction of Errors): An Erratum is issued for technical or editorial errors from production, layout, or editing (e.g., author affiliation omissions, typographical inaccuracies in tables). This applies only when the error does not compromise study results or conclusions.
2. Corrigendum (Author-Initiated Correction): A Corrigendum is published when authors identify involuntary errors in their article post-publication. This includes rectifications in formulas, references, field analysis data, or citation attributions needed for scientific accuracy, without invalidating fundamental research findings.
3. Retraction (Withdrawal): This is the most severe corrective measure. It applies when a manuscript has critical deficiencies invalidating its conclusions due to major methodological errors or serious ethical transgressions (plagiarism, redundant publication, data manipulation, or lack of informed consent). The original article remains in the digital repository, explicitly labeled "Retracted," linked to a formal retraction notice detailing reasons, to alert the scientific and academic community.

All correction or retraction requests are submitted for Editorial Committee evaluation. For transparency to readers and researchers, each corrective or retraction notice is electronically linked to the original document via its DOI.

Procedure for Handling Complaints and Appeals

Complaints or appeals formally begin with communication to the editor: Dr. Jhossmar Cristians Auza-Santiváñez (editor@revistavive.org). Upon receipt, the editor confirms acknowledgment and performs an initial assessment. The Editorial Committee is then informed and has two weeks to deliberate. The editor determines the relevant COPE protocol, guiding verification, resolution, and notifications.

The Editorial Committee may close the complaint or, if necessary, open a formal investigation, notifying parties via a technical report.

If an investigation proceeds, a designated editor coordinates it, requesting background information or defense statements from parties. In strict adherence to due process, authors always have the opportunity to present arguments and evidence. The final decision, based on all evidence, may dismiss the case, request more information, or validate the complaint. All resolutions are formalized by committee minutes.

When a complaint or allegation is confirmed valid, the resolution is communicated to affected parties and the accused's affiliated institution. If severe, the article will be modified, corrected, or retracted, with a formal note published in the next immediate issue to ensure scientific record transparency.

Vive Revista de Investigación en Salud applies strict criteria to identify and mitigate any conflicts of interest that might compromise evaluation integrity.

Conflict of Interest Policy

To ensure impartiality, authors must submit an anonymized manuscript. This document must omit any data identifying researchers, affiliated institutions, individuals, or funding sources. The journal's peer review uses a double-blind system, ensuring neither authors nor reviewers know each other's identities throughout evaluation.

The journal commits to appointing peer reviewers with proven research and scientific production in the article's specific thematic area. The editorial team ensures communication between authors and reviewers maintains a strictly academic and professional tone. Detailed evaluation result guidelines are in the peer review process section.

To ensure objective handling of submissions, Vive Revista de Investigación en Salud establishes the following action protocol:

• Anonymity Validation: Prior to peer review, the file's blind nature is rigorously verified to safeguard reviewer neutrality.
• Editorial Consensus: Based on technical evaluations, a joint deliberation with the editor determines the manuscript's resolution: acceptance without changes, acceptance with modifications (minor or substantial), or rejection.
• Formal Notification: The editor officially communicates the final decision to authors, substantiated by review reports.

Researchers must possess legal authorizations and permissions to disclose information involving third-party entities or individuals. It is mandatory to explicitly declare any use of prior results, informed consents, and acknowledgment of funding sources or collaborators who contributed to the research.

For technical submission requirements, consult the Instructions for Authors.

Data Sharing and Reproducibility Policy

Vive Revista de Investigación en Salud actively promotes the sharing and reproducibility of scientific data, strictly conditioned on confidentiality agreements and robust protection of research subjects' identities. As an integral part of the review process, the editorial board and peer reviewers reserve the right to request access to primary data supporting presented findings.

Authors are encouraged to link their manuscripts with corresponding datasets using bidirectional cross-references, facilitating navigation between the article and the dataset. Researchers may deposit their data on a platform of their choice, prioritizing internationally recognized repositories and data architectures to ensure transparency, long-term preservation, and open access.

Consistent with global reproducibility standards, the journal recommends using specialized digital ecosystems:

• Supplementary Data and Documents: Suggested for deposit in institutional repositories or platforms like Mendeley Data.
• Protocols and Methodological Materials: Management through the Open Science Framework (OSF) is encouraged to ensure research design traceability.
• Protocol Registration: For applicable studies (e.g., systematic reviews), prior registration on platforms like PROSPERO is urged to avoid duplication of efforts and ensure transparency.
• Code and Software: Scripts, analysis code, and development versions should be stored in version-controlled repositories, such as GitHub, enabling technical replicability by the scientific community.

Ethical Oversight Policy

The Editorial Committee of Vive Revista de Investigación en Salud requires adherence to the principles of the Singapore Statement on Research Integrity. Authors must detail applied ethical protocols and, upon request from editors or peer reviewers, provide evidence of implemented safeguards, with special emphasis on informed consent or assent processes and authorizations for database use.

Regarding graphic material, photographs featuring individuals require corresponding legal authorizations, ensuring their publication never violates participants' integrity or rights.

The content of published manuscripts is the exclusive responsibility of their authors and does not necessarily represent the official opinion or stance of the Editorial Board of Vive Revista de Investigación en Salud. Authors are strictly obligated to guarantee that the submitted work is original and unpublished.

Vive Revista de Investigación en Salud is distributed under the Creative Commons Attribution 4.0 International (CC BY 4.0) license. Under this scheme, authors' rights are safeguarded, while they grant the journal the necessary property rights for open-access dissemination and publication.

Privacy Policy

Identities and email addresses registered with Vive Revista de Investigación en Salud will be used exclusively for the stated editorial and scientific purposes of the institution. This information will not be transferred to third parties or external organizations under any circumstances. Furthermore, the journal maintains a strict policy of no advertising or marketing, ensuring its web platform is entirely dedicated to disseminating academic knowledge.

In compliance with current data protection legislation, users are informed that voluntary registration of their information on this site's official channels constitutes express consent for its incorporation into databases under the editorial team's responsibility. Such records will be processed solely to fulfill the journal's institutional objectives.

Data Anonymization and Ethical Safeguards: Authors are imperatively responsible for ensuring all presented information has undergone rigorous anonymization processes, adhering to international personal data protection standards. The use of real names or initials is strictly prohibited; generic identifiers or technical pseudonyms must be used instead.

For research involving clinical cases or iconographic material from patients, authors must explicitly declare informed consent was obtained in the manuscript. They must also confirm the implementation of all necessary technical measures to prevent subject re-identification, ensuring absolute confidentiality of sensitive health information.